In a significant move for continental health security, Cape Town-based research group Biovac has announced a major technology transfer agreement with Indian pharmaceutical firm Biological E. The Biovac initiative will enable the company to produce and distribute a pneumococcal conjugate vaccine (PCV14) across Africa. This marks a vital step towards self-sufficiency in vaccine manufacturing. The partnership will accelerate the growth…